The regulator’s reliance on double-blind, placebo-controlled trials with exhaustive inclusion and exclusion criteria is incompatible with today’s precision medicine.
If we don’t clean up our act and do something about predatory pricing scandals, we’ll wind up with Washington bureaucrats telling us what we can charge for our products.
December Back Talk.pdf Have you ever browsed through books on the history of advertising? Some of those ancient ads are curious: “They laughed when I sat down at the piano but when I started to play!” “At 60 miles an hour the loudest noise in this new Rolls-Royce comes from the electric clock.” Yesterday such…